Logo image of MRZ.CA

MIRASOL RESOURCES LTD (MRZ.CA) Stock Fundamental Analysis

TSX-V:MRZ - TSX Venture Exchange - CA6046801081 - Common Stock - Currency: CAD

0.37  0 (0%)

Fundamental Rating

0

MRZ gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 805 industry peers in the Metals & Mining industry. MRZ may be in some trouble as it scores bad on both profitability and health. MRZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MRZ has reported negative net income.
In the past year MRZ has reported a negative cash flow from operations.
In the past 5 years MRZ always reported negative net income.
In the past 5 years MRZ always reported negative operating cash flow.
MRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFMRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of -266.77%, MRZ is doing worse than 83.60% of the companies in the same industry.
The Return On Equity of MRZ (-622.97%) is worse than 76.15% of its industry peers.
Industry RankSector Rank
ROA -266.77%
ROE -622.97%
ROIC N/A
ROA(3y)-121.06%
ROA(5y)-87.62%
ROE(3y)-137.49%
ROE(5y)-98.57%
ROIC(3y)N/A
ROIC(5y)N/A
MRZ.CA Yearly ROA, ROE, ROICMRZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MRZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MRZ.CA Yearly Profit, Operating, Gross MarginsMRZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for MRZ has been increased compared to 1 year ago.
Compared to 5 years ago, MRZ has more shares outstanding
Compared to 1 year ago, MRZ has a worse debt to assets ratio.
MRZ.CA Yearly Shares OutstandingMRZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MRZ.CA Yearly Total Debt VS Total AssetsMRZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

MRZ has an Altman-Z score of -26.98. This is a bad value and indicates that MRZ is not financially healthy and even has some risk of bankruptcy.
MRZ has a Altman-Z score of -26.98. This is in the lower half of the industry: MRZ underperforms 76.65% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that MRZ is somewhat dependend on debt financing.
MRZ has a Debt to Equity ratio of 0.63. This is in the lower half of the industry: MRZ underperforms 73.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z -26.98
ROIC/WACCN/A
WACCN/A
MRZ.CA Yearly LT Debt VS Equity VS FCFMRZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 0.96 indicates that MRZ may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.96, MRZ is in line with its industry, outperforming 41.86% of the companies in the same industry.
A Quick Ratio of 0.96 indicates that MRZ may have some problems paying its short term obligations.
MRZ has a Quick ratio (0.96) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.96
MRZ.CA Yearly Current Assets VS Current LiabilitesMRZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.38% over the past year.
EPS 1Y (TTM)17.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MRZ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRZ.CA Price Earnings VS Forward Price EarningsMRZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRZ.CA Per share dataMRZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MRZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MIRASOL RESOURCES LTD

TSX-V:MRZ (7/16/2025, 7:00:00 PM)

0.37

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)02-24 2022-02-24
Inst Owners11.42%
Inst Owner ChangeN/A
Ins Owners36.25%
Ins Owner ChangeN/A
Market Cap30.01M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 18.72
P/tB 18.72
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -266.77%
ROE -622.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-121.06%
ROA(5y)-87.62%
ROE(3y)-137.49%
ROE(5y)-98.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 172.98%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.96
Altman-Z -26.98
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)102.57%
Cap/Depr(5y)113.08%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.58%
OCF growth 3YN/A
OCF growth 5YN/A